Login

Interview with Brian Cox, SurgePays CEO, regarding $SURG.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ; 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
A Legacy of Resilience: From Family Roots to IPO Success in Brazil's Real Estate Sector | Leandro Melnick , CEO,Even Construtora e Incorporadora SA.
00:10:00
Why Understanding Military History is Crucial for Democracy
00:10:00
Childhood Memories and Sibling Bonds|Madison Farkas,Professor,University of Wisconsin
00:10:00
Panu Porkka Discusses Strategic Milestones and Financial Targets at Verkkokauppa.com Capital Market Day | Panu Porkka, CEO, Verkkokauppa.com Oyj.
00:10:00
Introducing From Startup to Centaur a Bessemer Book|David Cowan,Partner,Bessemer Venture Partners
00:10:00
Precision in Small-Cap Investing: Magnus Larsson on TimesSquare’s Approach | Magnus Larsson – Portfolio Manager, TimesSquare Capital Management
00:10:00
Partnering for Success: Mazzone & Associates and Cherry Bekaert's Collaborative Approach
00:10:00
Leading early-stage venture capital firm providing pre-seed and seed capital to technology|Peter Goldberg,Founder and Partner,PLG Ventures
00:10:00
This venture capitalist chooses start-ups for investments|Oren Zeev,Founding Partner,Zeev Ventures
00:10:00
From Banking to Digital Entrepreneurship: A Conversation on Female Empowerment and Leadership
00:10:00
Arcadia Minerals: Leading Namibian Lithium Exploration
00:10:00
Strategic Growth and Financial Resilience: Insights from BNP Paribas CFO Lars Machenil

© 2026 Nehu